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The Roquin-1 protein binds to messenger RNAs
(mRNAs) and regulates gene expression posttran-
scriptionally. A single point mutation in Roquin-1,
but not gene ablation, increases follicular helper T
(Tfh) cell numbers and causes lupus-like autoim-
mune disease in mice. In T cells, we did not identify
a unique role for the much lower expressed paralog
Roquin-2. However, combined ablation of both
genes induced accumulation of T cells with an
effector and follicular helper phenotype. We showed
that Roquin-1 and Roquin-2 proteins redundantly
repressed the mRNA of inducible costimulator
(Icos) and identified the Ox40 costimulatory receptor
as another shared mRNA target. Combined acute
deletion increased Ox40 signaling, as well as Irf4
expression, and imposed Tfh differentiation on
CD4+ T cells. These data imply that both proteins
maintain tolerance by preventing inappropriate
T cell activation and Tfh cell differentiation, and that
Roquin-2 compensates in the absence of Roquin-1,
but not in the presence of its mutated form.
INTRODUCTION
T cells are required for humoral immune responses in which they
give help to B cells in the germinal center. This function is pro-vided by specialized CD4+ follicular helper T cells (Tfh cells)
that express the chemokine receptor CXCR5, the costimulatory
molecules PD-1 and Icos, the transcription factor Bcl6 as well as
the cytokine interleukin-21 (IL-21) (Crotty, 2011). Only recently,
Tfh cells have been established among Th1, Th2, Th17, and
Treg cell subsets by demonstrating that Bcl6 is the subset-deter-
mining transcription factor (Johnston et al., 2009; Nurieva et al.,
2009; Yu et al., 2009). Tfh cell differentiation has been proposed
to occur in a step-wise manner (Crotty, 2011). Priming by den-
dritic cells triggers upregulation of Icos on T cells, which is
required for the expression of Bcl6. Bcl6 in turn induces
CXCR5 expression (Choi et al., 2011), which allows T cell migra-
tion toward the T and B cell boundaries of follicles in the second-
ary lymphoid organs (Ansel et al., 1999; Kim et al., 2001). There,
the contact to B cells and sufficient costimulation through
several receptor-ligand pairs is required for the maintenance of
Tfh cells (Crotty, 2011). The initial upregulation and sustained
expression of Bcl6 (Baumjohann et al., 2011) is crucial for Tfh
cell differentiation, but additional transcription factors like
c-Maf and Batf (Bauquet et al., 2009; Betz et al., 2010; Ise
et al., 2011; Kroenke et al., 2012) cooperate in the program.
Furthermore, mice deficient for Irf4 cannot develop follicular
helper T cells (Bollig et al., 2012; Kwon et al., 2009), and Irf4
cooperates with Stat3 to regulate gene expression downstream
of IL-21 stimulation (Kwon et al., 2009). In contrast, Blimp1,
which is induced through IL-2 and Stat5 signaling, counteracts
commitment to this subset (Johnston et al., 2009, 2012; Nurieva
et al., 2012). The transcription factors involved in Tfh cell differ-
entiation also play a role in other subsets, suggesting functional
plasticity. In fact, it was recently shown that during Th1 cellImmunity 38, 655–668, April 18, 2013 ª2013 Elsevier Inc. 655
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Roquin-1 and 2 Control Tfh Cell Differentiationdifferentiation, the cells pass through a stage shared with Tfh
cells, which is marked by simultaneous expression of IL-21,
interferon-g (IFN-g), Bcl6, and T-bet. Subsequent input from
cytokines like IL-12 and balanced regulation of epigenetics and
gene expression then either enforces Th1 or Tfh cell commitment
(Nakayamada et al., 2011). Plasticity of the differentiation
program has also been demonstrated in an IL-21 reporter mouse
model in vivo (Lu¨thje et al., 2012). Because autoreactive Tfh cell
numbers are important players in the development of autoim-
mune disease (Hu et al., 2009; Linterman et al., 2009b), the
cellular transition point to the Tfh cell subset has to be tightly
controlled. The molecular basis for this decision is yet to be
defined.
Posttranscriptional gene regulation is well established in the
control of several cellular transition points in immune cells (Hoe-
fig and Heissmeyer, 2008). Roquin-1 (Rc3h1) is an RNA-binding
protein that posttranscriptionally downregulates Icosmessenger
RNA (mRNA) expression (Athanasopoulos et al., 2010; Glas-
macher et al., 2010; Yu et al., 2007). It recognizes the
30untranslated region (30UTR) of Icos mRNA and interacts with
the enhancer of decapping Edc4 and the helicase Rck that
promote mRNA decay (Glasmacher et al., 2010). A single point
mutation in Roquin-1 (named Roquin-1san) leads to a lupus-like
autoimmune phenotype in mice, marked by enhanced numbers
of Tfh cells and spontaneous germinal center formation (Vinuesa
et al., 2005). These findings imply an important role for Roquin-1
in Tfh cell differentiation or homeostasis. San/san mice develop
anti-nuclear and anti-DNA antibodies and show elevated surface
expression of Icos on all T cells (Vinuesa et al., 2005). This sug-
gests that increased Icos costimulation could lead to the autoim-
munity observed in the san/san mouse. In fact, a number of
studies show that experimentally induced constitutive costimu-
lation, which is normally restricted in a spatial or temporal
manner, can trigger autoimmunity. One example is the activa-
tion-induced tumor necrosis receptor superfamily 4 (Tnfrs4 or
Ox40) on T cells. Mice with ectopic coexpression of the Ox40
ligand on T cells develop autoimmune and autoinflammatory
phenotypes and have anti-DNA antibodies in the serum (Murata
et al., 2002). In line with this notion, CD28-deficiency, which nor-
mally prevents germinal center reactions, is functionally recon-
stituted in the context of the san/san genotype (Linterman
et al., 2009a). Conversely, heterozygosity of Icos partially res-
cues san/san-associated phenotypes (Yu et al., 2007). However,
increased Icos surface expression on all T cells is also observed
in mice that lack Roquin-1 in T cells or in the hematopoietic sys-
tem, but fail to elicit elevated follicular helper T cell numbers or
anti-nuclear antibody responses (Bertossi et al., 2011). These
findings question the previous concept in which impaired
posttranscriptional gene regulation of Icos mRNA by the
Roquin-1san protein leads to increased differentiation or expan-
sion of autoreactive Tfh cells, which then cause autoimmunity.
We have investigated the function of the paralog of Roquin-1,
Rc3h2 (Roquin-2) or also named Mnab, which has been previ-
ously described as a nucleic acid binding protein (Siess et al.,
2000). Both proteins share a similar organization of the really
interesting new gene (RING) finger, ROQ domain, and zinc finger
(Athanasopoulos et al., 2010). Here, we demonstrate that
Roquin-2 and Roquin-1 have redundant functions in T cells.
Both proteins posttranscriptionally repressed Icos and Ox40656 Immunity 38, 655–668, April 18, 2013 ª2013 Elsevier Inc.mRNA targets. T cells deficient in both Roquin-1 and Roquin-2
acquired a Tfh cell phenotype in the absence of immunization
implying that Roquin-2 sufficiently controls Tfh cell differentiation
upon Roquin-1 ablation. In contrast, in the sanroque mouse
strain Roquin-2 cannot complement, suggesting that the
Roquin-1san protein is able to inhibit Roquin-2 function.
RESULTS
Rc3h2 Gene Deficiency Causes Postnatal Death
To determine the redundant and nonredundant roles of the
Roquin-1 and Roquin-2 paralogs (Rc3h1 and Rc3h2), we
analyzed mice with a conditional Rc3h2 allele and generated a
monoclonal antibody that detected both proteins with similar
efficiencies (Figure 1A; see Figures S1A–S1E available online;
data not shown; EUCOMM mouse IKMC Project ID: 30078).
We demonstrated complete absence of both proteins when we
analyzed double genetically ablated Rc3h1/; Rc3h2/
(Rc3h1-2/) mouse embryonic fibroblast (MEF) cells by immu-
noblotting. In wild-type (WT) mouse tissues, we found that
Roquin-1 and -2 protein amounts were highest in extracts from
lymph node and thymus and slightly lesser amounts were
detected in extracts from brain, lung, and spleen (Figure 1B).
Both proteinswere only weakly detectable in extracts from heart,
muscle, and kidney. Interestingly, in all tissues analyzed, Roquin-
1 protein amounts were increased over Roquin-2 (Figure 1B).
Likewise, protein extracts from CD4+ T cells contained five times
more Roquin-1 than Roquin-2 protein (Figure S1F).
The insertion of the neomycin resistance gene cassette
abolished Roquin-2 expression (Figure 1A), rendering Rc3h2neo
a null allele. We found that Rc3h2neo/neo mice were born at
Mendelian ratio (Figure 1C), but very few individuals reached
adulthood (Figures 1C and 1D). A large proportion of
Rc3h2neo/neo mice died within the first days after birth, and the
strain exhibited decreased viability until weaning age (P20)
(Figure 1D). The previously observed malformation of the tail
and impairment of neural tube closure in Rc3h1-deficient mice
was not observed in newborn Rc3h2-deficient mice (data not
shown). However, similar to Rc3h1-deficient mice that die
shortly after birth (Bertossi et al., 2011), newborn Rc3h2neo/neo
mice revealed a somewhat immature lung phenotype with
decreased expansion of alveoli and delayed clearance of amnion
fluid from the alveolar space (Figure S1G). Although the exact
cause of death remains unknown, it was overcome by crossing
the mice on an outbred genetic background of Naval Marine
Research Institute (NMRI) mice (Figure S1H). A similar strategy
conferred a partial rescue of lethality in Rc3h1-deficient
mice (Bertossi et al., 2011). The few surviving male and
female Rc3h2neo/neo individuals on the C57BL/6 background
appeared healthy and were fertile (data not shown). They had a
phenotype of smaller size and decreased body mass compared
with WT littermates (data not shown), which, on the outbred
NMRI genetic background, was only seen in male individuals
(Figure 1E).
Deletion of Rc3h2 Does Not Affect Immune Cell
Homeostasis
To analyze Roquin-2 function specifically in T cells, we
generated Rc3h2fl/fl; Cd4-cremice. Roquin-2 protein was hardly
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Figure 1. Systemic Deletion of Rc3h2 Results in Postnatal Lethality and Reduced Body Size
(A) Immunoblot analysis of Roquin-1, Roquin-2, Rabgap1 (the Rabgap1 gene is located 50 adjacent to Rc3h2), and tubulin expression in Rc3h1-2fl/fl, Rc3h1/,
Rc3h2neo/neo (Roquin-2-deficient), and Rc3h1-2/ immortalized MEFs. Rc3h1-2/ cells were obtained by retroviral cre transduction of Rc3h1-2fl/fl MEFs.
(B) Protein expression of Roquin-1 and Roquin-2 in different tissues with tubulin and GAPDH as loading controls. Data are representative for two (A, Rabgap1),
three (A, Roquin-1, Roquin-2), and four (B) experiments.
(C) Genotype frequency of offspring from intercrosses of Rc3h2+/neo mice.
(D) Kaplan-Meier survival curves of mice with the indicated genotypes.
(E) Body-weight curves of male or female mice on a Naval Marine Research Institute (NMRI) outbred strain genetic background. Weight reduction in male
Rc3h2neo/neo mice was already significant at day 1. Genotypes are indicated in the figure, and statistical significances were calculated by Student’s t test
(***p < 0.001). Data are represented as mean ± SD. See also Figure S1.
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Roquin-1 and 2 Control Tfh Cell Differentiationdetectable in extracts from mature CD4+ T cells (Figure 2A, left
panel), and strongly reduced in thymocyte extracts (Figure 2A,
right panel) of these mice. Compared to controls, Rc3h2fl/fl;
Cd4-cre mice showed no difference in thymocyte development
(Figure 2B) and no differences in T cell CD62L and CD44 surface
marker expression that discriminate naive from effector or mem-
ory T cells (Figure 2C). Furthermore, Rc3h2fl/fl; Cd4-cremice did
not show increased Icos surface expression on single positive
thymocytes or peripheral T cells (Figure 2D). Similar to Rc3h1fl/fl;
Cd4-cre mice (Bertossi et al., 2011), Rc3h2fl/fl; Cd4-cre mice
showed no differences in the percentage of follicular helper
T cells (Tfh) or germinal center (GC) B cells (Figure 2E; Figure 2F).
Even in Rc3h2-deficient animals, the immune cell homeostasis
appeared normal, when we analyzed Rc3h2neo/neo mice on a
mixed C57BL/6 and NMRI background (Table S1). Our analysestherefore did not reveal a nonredundant role for Roquin-2 in
peripheral T cells or other immune cells.
Roquin-1 and Roquin-2 Redundantly Control T Cell
Homeostasis
The normal immune system in Rc3h2-deficient mice (Figure 2;
Table S1) and the comparatively mild immune dysregulation
seen in Rc3h1-deficient mice (Bertossi et al., 2011) contrast
the excessive autoimmunity that is observed in Rc3h1san/san
mice (Vinuesa et al., 2005). This prompted us to investigate a
functional redundancy of both genes in the T cell-specific com-
bined gene ablation in Rc3h1-2fl/fl; Cd4-cre mice (Figure 3A).
Already at young age, these animals developed lymphadenopa-
thy and splenomegaly with increased spleen weight and cellu-
larity (Figure 3B). The mice exhibited a decreased frequency ofImmunity 38, 655–668, April 18, 2013 ª2013 Elsevier Inc. 657
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Figure 2. Deletion of Rc3h2 in T Cells Does Not Affect Thymic Development, T Cell Differentiation, or Icos Expression
(A) Immunoblot analysis of Roquin-1 and Roquin-2 expression in CD4+ T cells (left) or thymocytes (right). Protein expressions relative toWT are 12% for Roquin-2
and 97% for Roquin-1 in Rc3h2-deficient CD4+ T cells and in thymocytes 63% for Roquin-2 and 108% for Roquin-1 (quantified by ImageJ). Representative flow
cytometric analysis shows the frequencies of thymocyte subsets (B) or of CD62Lhi CD44lo, CD62Llo CD44hi or CD62Lhi CD44hi splenic CD4+, or CD8+ T cells (C).
(D) Relative median fluorescence intensity (MFI) of Icos in CD4+ CD8 or CD8+ CD4 thymocytes or splenic Rc3h2fl/fl; Cd4-cre T cells, normalized to the
respective Cd4-cre control T cell subset. Bars indicate medians.
(E and F) Representative contour plots showing proportions of splenic follicular helper T cells (PD-1hi CXCR5hi) pregated onCD4+ (E) and of germinal center B cells
(GL-7hi CD95hi) pregated on B220+ (F). Genotypes are indicated in the figure, and data are representative for 3 experiments (A) or for 10 (B), 12 (C), and 5 (E–F)
mice per genotype. See also Table S1.
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Roquin-1 and 2 Control Tfh Cell Differentiationnaive CD62Lhi CD44lo and a strongly increased frequency of
activated CD62Llo CD44hi T cells. This phenotype was evident
for CD4+ and CD8+ T cells and therefore different from Rc3h1fl/fl;
Cd4-cre mice, which did not show activation of CD4+ T cells
(Bertossi et al., 2011). In the CD8+ T cell lineage, the activated
phenotype was even more pronounced in the absence of both
paralogs, with almost no naive and less CD62Lhi CD44hi T cells
(Figures 3C and 3D). We observed a significant decrease in ab-
solute cell numbers for total CD4+, naive CD4+ and naive CD8+
T cells, whereas CD62Llo CD44hi CD8+ T cells were significantly
increased (Figure 3D). Notably, no compensatory upregulation of658 Immunity 38, 655–668, April 18, 2013 ª2013 Elsevier Inc.Roquin-2was detected in CD4+ or CD8+ T cells fromRc3h1-defi-
cient mice or in CD4+ T cells from Rc3h1san/san mice (Figures 3E
and 3F; Figure S1F). The peripheral and thymic T regulatory
(Treg) cell proportions of CD4+ T cells were significantly
increased, but this did not correspond with a significant increase
in absolute numbers (Figures S2A and S2B). Taken together,
Rc3h1-2fl/fl; Cd4-cre mice exhibit the prominent phenotype of
increased CD8+ CD62Llo CD44hi cells seen in Rc3h1fl/fl; Cd4-
cre mice. In addition, they develop lymphadenopathy, spleno-
megaly, and the strongly increased CD62Llo CD44hi phenotype
of CD4+ and CD8+ cells of the Rc3h1san/san mutant. These data
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Figure 3. Combined Ablation of Roquin-1 and Roquin-2 in T Cells Reveals Functional Redundancy
(A) Immunoblot analysis confirming the ablation of Roquin-1 and Roquin-2 in CD4+ T cells with tubulin as loading control.
(B) Spleen weight (left graph) and splenocyte number (right graph).
(C and D) Representative contour plots (C) and corresponding cells numbers (D) from CD4+ (upper panel) or CD8+ (lower panel) T cells, showing splenic CD62Lhi
CD44lo, CD62Llo CD44hi, or CD62Lhi CD44hi T cells subsets.
(E and F) Bars indicate means. Immunoblot analysis of CD8+ (E) or CD4+ T cells (F) is shown. Statistical significances were calculated by Student’s t test and
Tukey’s multiple comparisons test (*p < 0.05; **p < 0.01; ***p < 0.001). Genotypes are indicated in the figure, and data are represented as mean ± SD and
representative for four (A), two (E), and 1–3 (F) experiments and 7–13 (C) mice per genotype and represented as mean ± SD. See also Figure S2.
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Figure 4. Both Roquin-1 and Roquin-2 Interact with Edc4 and Regulate Icos Expression
(A and B) Representative histograms (A) and relative median fluorescence intensity (MFI) (B) of Icos in CD62Lhi CD44lo, CD62Llo CD44hi or CD62Lhi CD44hi CD4+
(upper panel), or CD8+ (lower panel) Rc3h1-2fl/fl; Cd4-cre T cells, normalized to Icos expression on Cd4-cre T cells. Bars indicate medians.
(legend continued on next page)
Immunity
Roquin-1 and 2 Control Tfh Cell Differentiation
660 Immunity 38, 655–668, April 18, 2013 ª2013 Elsevier Inc.
Immunity
Roquin-1 and 2 Control Tfh Cell Differentiationtherefore suggest redundant functions of Roquin-1 and Roquin-
2 in T cells.
Roquin-1 and Roquin-2 Redundantly Repress Icos
mRNA
Icos expression in Rc3h1-2fl/fl; Cd4-cre mice was increased on
all T cells and much higher compared to Rc3h1san/san or
Rc3h1fl/fl; Cd4-cremice (Figure 4A–4C). We therefore addressed
the redundancy of both paralogs by comparing their association
with Edc4, which is a cofactor of mRNA decapping and an inter-
action partner of Roquin-1 (Glasmacher et al., 2010). We used
WT, single- and double-deficient MEF cells for anti-Roquin-1
and anti-Roquin-2 immunoprecipitation. Edc4 was equally well
detected in immunoprecipitates from Rc3h2neo/neo or Rc3h1/
MEF cell extracts (Figure 4D). Consistent with Edc4 interacting
equally with both paralogs, the detection was maximal in immu-
noprecipitations from extracts of WT and absent in double-defi-
cient MEFs (Figure 4D). We then assayed the recognition of Icos
mRNA by amino-terminal fragments of Roquin-1 (aa 1–441) and
Roquin-2 (aa 1–438) proteins. Electrophoretic mobility shift
assays (EMSA) and filter binding assays showed similar charac-
teristics of both proteins binding to the previously mapped cis-
element (Icos nucleotides [nts] 700–800) (Glasmacher et al.,
2010) (Figures 4E–4H). Roquin-1 and Roquin-2 proteins inter-
acted much stronger with an Icos RNA-oligonucleotide
harboring the cis-element (Icos nts 700–800) compared with
another Icos RNA-oligonucleotide without the cis-element (Icos
nts 600–700) (Figure 4F). The specificity of binding was
confirmed by efficient competition with unlabeled Icos nts
700–800 and by much less efficient competition with Icos nts
600–700 (Figures 4G–4H). Finally, to prove functional
redundancy we adenovirally introduced Roquin-1 protein or
Roquin-2 isoforms into Rc3h1-deficient T cells. We employed
a CAG-CARstop-fl transgenic mouse (K.H., data not shown)
(Figures S3A–S3C) that enabled the conditional expression of a
truncated human coxsackie adenovirus receptor (CAR) (Wan
et al., 2000). We generated Rc3h1fl/fl; CAG-CARstop-fl; Cd4-cre
mice and transduced CD4+ T cells with adenoviruses expressing
Roquin-1 and Roquin-2. In these experiments, both Roquin-2
isoforms (aa 1–1125 or aa 1–1187) downregulated Icos in a
dose-dependent manner and their activity was undistinguish-
able from WT Roquin-1 protein, whereas an inactive mutant of
Roquin-1 (aa 1–509) showed no effect (Figure 4I). Therefore,
Roquin-1 and Roquin-2 proteins independently engage in the
same molecular interactions with Edc4 protein and with Icos(C) Relative median fluorescence intensity of Icos on CD62Llo CD44hi CD4+ T cells
Bars indicate medians.
(D) Immunoprecipitation (IP) with magnetic beads coupled to an antibody, which
Roquin-1, and Roquin-2 proteins were detected by immunoblot analysis in IP an
(E) Electrophoretic mobility-shift assay with increasing amounts (0–40 pmol) of re
transcribed human Icos mRNA (1 pmol) either containing the 30UTR (full-length,
(F) Comparison of relative retention of Roquin-1 (aa 1–441) or Roquin-2 (aa 1–438)
(G and H) Filter-binding assays using 500 nM recombinant Roquin-1 (aa 1–441) (F
and competed with cold human Icos nts 700–800 or nts 600–800 in molar exces
(I) Adenoviral transduction of CD4+ T cells fromRc3h1fl/fl; CAG-CARstop-fl; Cd4-cre
or two isoforms of Roquin-2 (aa 1–1125 or aa 1–1187). Surface staining of Icos and
right graph shows a histogram overlay of Roquin-1hi and Roquin-2hi cells. All blot
Student’s t test (*p < 0.05; **p < 0.01). Genotypes are indicated in the figure, and da
of three to four (F–H) experiments. See also Figure S3.mRNA and can redundantly downregulate Icos expression in
T cells.
Combined Loss of Rc3h1 and Rc3h2 Induces
Differentiation of Tfh Cells
Rc3h1-2fl/fl; Cd4-cre mice also exhibited strongly increased fre-
quencies and absolute numbers of PD-1hi CXCR5hi Bcl6hi Tfh
cells compared to Cd4-cre control and Rc3h1fl/fl; Cd4-cre
mice in the absence of immunization (Figure 5A; Figure 5B).
These Tfh cells were functional, as demonstrated by the
concomitantly increased frequencies and numbers of germinal
center B cells (Figures 5C and 5D). However, many of the
Rc3h1-2fl/fl; Cd4-cre animals had spleens with strongly
reduced B cell counts and severe immune dysregulation (Fig-
ure 5E; Figure S4A). Unlike Rc3h1san/san mice, Rc3h1-2fl/fl;
Cd4-cre animals did not show spontaneous germinal center
formation with the production of anti-nuclear antibodies (data
not shown). By analyzing spleen sections by histology, we
found a strong reduction in white pulp areas devoid of F4/
80+ macrophages (Figures S4B and S4C). This appeared to
be due to unorganized or entirely absent follicular structures.
Different from control spleens, B220+ B cells were almost not
detected and T cell areas were unorganized, with CD8+
T cells being more affected than CD4+ T cells (Figure 5E). In
addition, MOMA-1+ metallophilic macrophages appeared
scattered and did not surround a follicle-like structure with a
marginal zone (Figure 5E). The profound perturbations could
result from altered communication of lymphocytes with the
accessory cells in the spleen that is known to be essential for
the formation and integrity of the follicle structure (Schneider
et al., 2004). In fact, in the few follicle-like structures that
could be found in the spleens of adult Rc3h1-2fl/fl; Cd4-cre
mice we noticed that the ER-TR7+ reticular fibroblasts of
the T cell zone appeared dispersed (Figure S4D), whereas
follicular dendritic cells stained with anti-FDC-M1 could still
be detected within a central network (Figure S4E). Although
spleen sections from an only 3-week-old mouse were less
affected, the frequency of intact primary follicles was also
reduced (Figures S4F–S4J).
We then addressed whether adoptive transfer of polyclonal
T cells with an acute deletion of Rc3h1-2 alleles revealed
spontaneous Tfh differentiation in an intact splenic environment
(Figures 5F–5K). We achieved this by infecting cells with a cre-
IRES-Thy1.1 encoding MSCV retrovirus, which allowed identifi-
cation of transduced cells via Thy1.1 expression. The sharedof the indicated genotypes, normalized to Icos expression on Cd4-cre T cells.
recognizes both Roquin-1 and Roquin-2, of protein extracts from MEFs. Edc4,
d input.
combinant Roquin-1 (aa 1–441) or Roquin-2 (aa 1–438), incubated with in vitro-
nts 1–2540) or lacking the 30UTR (coding sequence [CDS], nts 1–600).
with human Icos fragments nts 700–800 or nts 600–700 by filter-binding assays.
) or Roquin-2 (aa 1–438) (G) incubated with human Icos nts 700–800 fragments
s.
mice with adenovirus encoding an inactive Roquin-1 (aa 1–509), Roquin-1WT,
intracellular staining of Roquin-1 and2 protein is shown in contour plots. The
s in (I) are pregated on CAR+ cells. Statistical significances were calculated by
ta are representative for six (A), two (C andD), and three (E and I) ormeans ± SD
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Figure 5. Combined Loss of Rc3h1 and Rc3h2 Drives Follicular T Helper (Tfh) Cell Differentiation
(A) Representative contour plots of splenic Tfh cells (PD-1hi CXCR5hi) pregated on CD4+ T cells with histogram overlays showing Bcl6 expression.
(B) Percentage of Tfh cells (of CD4+ T cells, upper panel) or Tfh cell numbers (lower panel). Bars indicate means.
(C) Representative contour plots of splenic germinal center B cells (GCB; GL-7hi CD95hi) pregated onB220+ B cells, and (D) percentages of GCB cells (of B220+ B
cells, upper panel) or GC B cell numbers (lower panel). Bars indicate means.
(E) Consecutive cryosections from spleens, stained for CD4, CD8, B220, and MOMA-1 (scale bar represents 100 mm).
(F) Protein expression of Roquin-1 and Roquin-2 in cre-transduced CD4+ T cells.
(G–I) Frequencies of Tfh cells (pregated on CD4+ Thy1.1+) on day 6 (G) or GCB cells (pregated on B220+) on day 8 (H), as well as proliferation of CD4+ Thy1.1+ cells
on day 6 (I) after transfer of MSCV-cre-Thy1.1-transduced WT or Rc3h1-2fl/fl cells (Th1-differentiated) into Icos/ mice.
(legend continued on next page)
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Roquin-1 and 2 Control Tfh Cell Differentiationtransitional stage of Th1 and Tfh cell differentiation (Nakayamada
et al., 2011) prompted us to ablate Rc3h1 and Rc3h2 genes
acutely within a 5 day Th1 cell culture before adoptive transfer
into Icos-deficient hosts, which are impaired in endogenous
Tfh cell generation (Choi et al., 2011). These experiments
showed that acute loss of Rc3h1-2 triggered Tfh cell differ-
entiation of the transferred cells and induced host B cells to
spontaneously undergo germinal center B cell differentiation
(Figures 5G and 5H). CD4+ T cells from Rc3h1-2fl/fl mice lost
Roquin-1 and Roquin-2 protein expression five days after
transduction (Figure 5F) and showed derepressed Icos
expression (Figure S4K). Furthermore, IL-21 single- and IL-21
and IFN-g double-producers were increased after restimulation
of these cells with phorbol myristate acetate (PMA) and
ionomycin (Figure S4L). On day 6 after transfer, Thy1.1+ CD4+
T cells that originated from Rc3h1-2fl/fl mice had proliferated
vigorously (Figure 5I) and contained an elevated frequency and
number of Tfh cells compared to WT Thy1.1+ CD4+ T cells
(Figures 5G and 5J). The increased number of Tfh cells in the
Thy1.1+ CD4+ T cells from Rc3h1-2fl/fl mice declined and
reached similar Tfh cell numbers as WT cells within the next
2 days (Figure 5J). Six days after transfer of Rc3h1-2-deficient
T cells, total B cell numbers moderately increased but declined
until day 8, at which GC B cell numbers and frequencies
were increased. This did not affect the frequency of CD138+
plasma cells (data not shown; Figures 5H and 5K). Our data
showed that the increased number of follicular helper T cells in
Rc3h1-2fl/fl; Cd4-cremice was due to increased Tfh cell differen-
tiation. The differentiation did not require ex vivo T cell activation
because it was also observed after adoptive transfer of sorted
naive CD4+ T cells from Rc3h1-2fl/fl; Cd4-cre mice (data not
shown).
Roquin-1 and Roquin-2 Deficiency Induces Irf4
and the Alternative NF-kB Pathway
Having established thatRc3h1-2-deficient T cells undergo spon-
taneous Tfh cell differentiation in the absence of immunization,
we tested expression of critical transcription factors of Tfh cells,
among them Bcl6 and Irf4 (Bollig et al., 2012; Johnston et al.,
2009; Kwon et al., 2009; Nurieva et al., 2009; Yu et al., 2009).
We found increased amounts of Irf4 protein after acute deletion
of Rc3h1 and Rc3h2 genes in Th1 cells as well as in CD4+ T cells
isolated from Rc3h1-2fl/fl; Cd4-cre mice (Figures 6A–6D, top
panels). Because Irf4 is a downstream target of NF-kB signaling,
we tested spontaneous activation of the canonical (Figure 6B) or
alternative pathway (Figure 6C) in Rc3h1-2-deficient Th1 cells.
Enhanced IkBa degradation was not evident, but p65 protein
amounts and phosphorylation were modestly increased. Phos-
phorylation of IkBa also appearedmodestly elevated (Figure 6B).
In contrast, mediators of the alternative pathway were strongly
affected. Both p100 and Relb expression was increased, as
was p100 processing to p52 (Figure 6C), which led to dramatic
nuclear accumulation of p52 (Figure 6E). Also, CD4+ T cells
from Rc3h1-2fl/fl; Cd4-cre mice displayed enhanced p100 pro-(J and K) Cell numbers of Tfh (J) or GC B (K) cells at day 6, 7, and 8 after
parisons test (*p < 0.05; **p < 0.01; ***p < 0.001). Genotypes are indicated in
mice per genotype, and six (F) or five (G–K) experiments with two (G, H, J, K)
Figure S4.cessing and Irf4 protein amounts (Figure 6D). We hypothesized
that spontaneous Irf4 and NF-kB activation in Rc3h1-2-deficient
cells was a result of posttranscriptional derepression of one or
more shared Roquin-1 and Roquin-2 targets in the alternative
NF-kBpathway.We therefore testedmRNAexpression of candi-
date genes in the NF-kB pathway by quantitative PCR (Fig-
ure 6F). During testing of Ikka, Ikkb, Ikkg, NIK, Ciap1, Ciap2,
Traf2, Traf3, and Tradd gene expression, we did not find an in-
duction of these mRNAs in Rc3h1-2-deficient cells, whereas
Icos, Relb, Irf4, and Ox40 were increased (Figure 6F). Ox40
had been included as a candidate target gene because a small
hairpin RNA (shRNA) that downregulated Rc3h1 (Glasmacher
et al., 2010) upregulated Ox40 expression (data not shown).
Importantly, Ox40 has been shown to activate the NF-kB
pathway (Murray et al., 2011) and was also increased on the pro-
tein level on the surface of CD4+ T cells from Rc3h1-2fl/fl; Cd4-
cre, as well as Rc3h1fl/fl; Cd4-cre but not Rc3h2fl/fl; Cd4-cre,
mice (Figure 6G). We then used an agonistic antibody to deter-
mine the effect of Ox40 stimulation in Th1 cells. Triggering of
Ox40 clearly recapitulated alternative NF-kB activation in
Rc3h1-2-deficient cells by inducing p100 processing to p52,
but this stimulation alone was not sufficient to increase the Irf4
protein amounts (Figure 6H).
Ox40 is Posttranscriptionally Repressed by Roquin-1
and Roquin-2 Proteins
To find out whether Ox40 is a direct target, we tested binding
of Roquin-1 and Roquin-2 proteins to the Ox40 mRNA. EMSA
experiments showed that Ox40 and Icos mRNAs were similarly
bound by Roquin-1 (Figure 7A) and Roquin-1 or Roquin-2 were
indistinguishably bound to Ox40mRNA (Figure 7B). In filter bind-
ing assays, the specific retention of the 32P-labeled Ox40 30UTR
by Roquin-1 was effectively competed by an RNA-oligonucleo-
tide with and, to a lesser extent, without the cis-element of the
30UTR of Icos (compare Figure 7C Icos nts 700–800 with Icos
nts 600–700). A similar binding and competition was observed
for Roquin-2 (Figure 7D). We also demonstrated that Ox40 was
downregulated in cells that overexpress Roquin-1 (Figures 7E
and 7F). Specifically, we transduced Rc3h1-2-deficient MEF
cells sequentially to express Ox40 and Roquin-1. Importantly,
the downregulation depended on the expression of full-length
Ox40 mRNA and WT Roquin-1 and did not occur when we ex-
pressed either Ox40 coding sequence with WT Roquin-1 or
Ox40 full-length with the inactive mutant of Roquin-1 (aa 1–
509) (Figure 7E). Finally, by using adenoviral transduction of
CD4+ T cells from Rc3h1fl/fl; CAG-CARstop-fl; Cd4-cre mice, we
demonstrated that endogenous Ox40 surface expression was
downregulated to a similar extent by a comparable overexpres-
sion of the Roquin-1 protein or either isoform of Roquin-2 (Fig-
ure 7F). By this we present Ox40 as another posttranscriptional
target of Roquin-1 and Roquin-2, which might therefore
contribute to the observed activation of T cells and the increased
Tfh cell differentiation, as well as the development of autoim-
mune disease.transfer. Statistical significances were calculated by Tukey’s multiple com-
the figure and data are representative for 12 (A–D) and more than three (E)
and three (I) mice per group. Data are represented as mean ± SD. See also
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Figure 6. Rc3h1-2 Deletion Elevates Irf4 and Ox40 Expression and Leads to Activation of the NF-kB Pathway
Immunoblot analysis of protein lysates from WT or Rc3h1-2fl/fl CD4+ T cells after cre-transduction, showing Irf4 expression (A) and factors involved in the ca-
nonical (B) or alternative NF-kB pathway (C), each representing an independent experiment.
(D) Immunoblot analysis of purified CD4+ T cells, showing factors of the noncanonical NF-kB pathway.
(E) Immunoblot analysis of cytoplasmic and nuclear extracts from WT or Rc3h1-2fl/fl CD4+ T cells after cre-transduction. Data are representative for four (D) and
three (E) experiments.
(F) Quantitative PCR analysis of factors involved in NF-kB signaling. Data are representative for three biological replicates from WT or Rc3h1-2fl/fl CD4+ T cells
after cre-transduction.
(G) Relative MFI of Ox40 in Roquin-1- and Roquin-2-deficient CD4+ T cells normalized to Cd4-cre T cells. Bars show medians.
(H) Immunoblot of Th1-differentiated CD4+ T cell lysates from C57BL/6 mice, treated with 10 mg/ml isotype control antibody or anti-Ox40 (OX86) for 3 days,
showing factors of the alternative NF-kB pathway. Genotypes are indicated in the figure, and data are representative for three experiments. Statistical signifi-
cances were calculated by Tukey’s multiple comparisons test (*p < 0.05). Data are represented as mean ± SD. See also Table S2.
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Roquin-1 and 2 Control Tfh Cell DifferentiationDISCUSSION
In this study we defined Ox40 as a new target of Roquin-1 and
Roquin-2 through direct binding and 30UTR-dependent post-
transcriptional repression. Combined ablation of Rc3h1 and
Rc3h2 in T cells induced the expression of Ox40 and the activa-664 Immunity 38, 655–668, April 18, 2013 ª2013 Elsevier Inc.tion of the alternative NF-kB pathway, which was also observed
in WT cells after stimulation of Ox40. In addition, we found that
Rc3h1-2-deficient T cells contained elevated expression of the
NF-kB target genes Relb and Irf4 (Basak et al., 2008; Grumont
and Gerondakis, 2000; Sasaki et al., 2008). Although stimulation
of Ox40 alone did not induce Irf4, we nevertheless think that
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Figure 7. Roquin-1 and Roquin-2 Redundantly Control Ox40 Expression
(A and B) EMSA performedwith (A) 0–20 pmol of recombinant Roquin-1 (aa 1–441) protein, incubated with 1 pmol of in vitro-transcribed human Icos (full-length) or
mouse Ox40 (full-length) mRNA or (B) with 1 pmol mouse Ox40 (full-length) mRNA and 0–20 pmol Roquin-1 (aa 1–441) or Roquin-2 (aa 1–438).
(C and D) Filter-binding assay that used recombinant Roquin-1 (aa 1–441) (C) or Roquin-2 (aa 1–438) (D) incubated with mouse Ox40 30UTR and competed with
cold human Icos nts 700–800 or with cold human Icos nts 600–800 in molar excess as indicated.
(E) Representative contour blots and histogram overlay (right) of Ox40 and Roquin-1 (as Thy1.1) in Rc3h1-2-deficient MEFs, transduced with a retrovirus
encoding full-length (FL) or coding sequence (CDS) Ox40 mRNA, and superinfected with a retrovirus encoding IRES-Thy1.1 with inactive Roquin-1 (aa 1–509) or
WT Roquin-1.
(F) Contour plots showing surface Ox40 and intracellular Roquin-1 and Roquin-2 expression after adenoviral transduction of CD4+ T cells from Rc3h1fl/fl; CAG-
CARstop-fl; Cd4-cre mice with an inactive Roquin-1 (aa 1–509), Roquin-1 WT, or two isoforms of Roquin-2 (aa 1–1125 or aa 1–1187). The right graph shows a
histogram overlay of Roquin-1hi and Roquin-2hi cells. All plots in (F) are pregated on CAR+ cells. Statistical significances were calculated by Student’s t test
(*p < 0.05; **p < 0.01). Data are representative for five (A), two (B), and three (E and F) or the means ± SD of three to four (C and D) experiments.
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Roquin-1 and 2 Control Tfh Cell Differentiationcellular Irf4 amounts are increased as a result of Ox40 in
conjunction with other signals in Rc3h1-2-deficient T cells. How-
ever, we cannot rule out Irf4 as a direct target of Roquin-1 and
Roquin-2. Increased Irf4 activity might augment Tfh cell numbersbecause Irf4-deficient T cells are greatly impaired in this differen-
tiation program (Bollig et al., 2012; Kwon et al., 2009). Irf4 can
also directly bind the promoter of Icos and induce its expression
(Zheng et al., 2009), which could additionally explain theImmunity 38, 655–668, April 18, 2013 ª2013 Elsevier Inc. 665
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Roquin-1 and 2 Control Tfh Cell Differentiationexceedingly high Icos surface expression on Rc3h1-2-deficient
T cells. Interestingly, the Irf4-binding protein Def6 has been
shown to negatively regulate Irf4 transcriptional activity (Chen
et al., 2008), and deficiency of Def6 correlates with systemic
lupus-like autoimmunity (Fanzo et al., 2006). Similarly, Ox40
has been implicated in a large number of autoimmune diseases
(Croft, 2010), whereas deletion of Ox40 together with CD30
rescues lethal autoimmunity in Foxp3-deficient mice (Gaspal
et al., 2011).
Both Icos and Ox40 are important for the survival of effector
T cells (Simpson et al., 2010; Weinberg, 2010). Constitutive
Ox40 triggering through transgenic expression of the Ox40
ligand on T cells leads to massive induction of effector memory
CD4+ but not CD8+ T cells (Murata et al., 2002). Ox40 is linked
to Tfh cell development because transgenic Ox40L overexpres-
sion on dendritic cells increases the appearance of CD4+ T cells
with a CD62Llo phenotype, which accumulate in germinal
centers after immunization (Brocker et al., 1999). In a very recent
publication, IFN-g has been proposed to be a potential new
target of Roquin-1 and involved in the accumulation of short-
lived effector CD8+ T cells (SLEC) with enhanced effector
function in san/san mice (Chang et al., 2012). However, the so
far presented evidence cannot rule out indirect stabilization of
IFN-g mRNA in SLECs from san/san mice. Such stabilization of
the mRNA of IFN-g and other cytokines has been reported in
the context of Ox40 stimulation (Mestas et al., 2005). Ox40 acti-
vates NF-kB and overlaps with downstream Icos signaling in the
activation of PI3K (Gigoux et al., 2009; So et al., 2011). Remark-
ably, the extent of PI3K activation during immunization has been
shown to determine the magnitude of the germinal center reac-
tion (Rolf et al., 2010). Our findings therefore imply that both cos-
timulatory pathways of Icos and Ox40 work in a redundant and
cooperative manner to enhance Tfh cell differentiation in
Rc3h1-2-deficient CD4+ T cells.
We showed that combined Rc3h1 and Rc3h2 deficiency in
T cells led to spontaneous Tfh and GC B cell differentiation in
the absence of immunization but did not induce anti-nuclear
antibodies. This can be due to several reasons. The observed
changes in san/san mice might require the presence of the
mutation in cells outside of the T cell compartment. On the other
hand, we propose that the profound perturbation of the splenic
microarchitecture might no longer permit progression toward a
lupus-like disease. At this point we do not know which trans-
acting factor produced by Rc3h1-2-deficient T cells interferes
with the follicle organization.
In light of the determined functional redundancy, it was
remarkable that the five-times lower expression of Roquin-2
compared to Roquin-1 in CD4+ T cells did not correlate with
the functional impact of the protein in the individual mouse
models. This was not only true for Icos regulation but also
for the control of effector memory T cell and Tfh cell pheno-
types. Notably, Roquin-2 protein was not upregulated in
Rc3h1-deficient T cells or in CD4+ T cells from Rc3h1san/san
mice. Considering these mouse models, we find that (1)
even very low amounts of Roquin-2 in CD4+ T cells were
able to functionally compensate for most of the loss of func-
tion due to ablation of Rc3h1. (2) The same amount of
Roquin-2 protein in T cells that also express the Roquin-1san
protein was much less able to complement the hypomorphic666 Immunity 38, 655–668, April 18, 2013 ª2013 Elsevier Inc.function of Roquin-1san in posttranscriptional gene regulation
(Vinuesa et al., 2005; Yu et al., 2007), and (3) deletion of
Rc3h2 in T cells that express WT Roquin-1 had no obvious ef-
fect. (4) In contrast however, we found that combined deletion
of Rc3h2 and Rc3h1 dramatically increased Icos and Ox40
surface expression and massively induced Tfh cell differentia-
tion as well as effector memory phenotypes in CD4+ and CD8+
T cells. We therefore conclude that the redundant activity of
Roquin-2 must be inhibited in the presence of Roquin-1san
or Roquin-1 WT proteins. The nature of this inhibition is
unknown but might involve dominant-negative effects, compe-
tition for a shared and limiting factor, or negative feedback
regulation.
The evolutionary advantage of Rc3h1 and Rc3h2 gene
duplication can be seen in a safe guard system that protects
us from autoimmunity and tumorigenesis. It might also involve
a so-far undiscovered diversification of both paralogs, consid-
ering the postnatal lethality of the individual genetically ablated
mice. Our present study reveals that in T cells, Roquin-1 and
Roquin-2 proteins redundantly restrict T cell activation and cos-
timulation via Icos and Ox40 to prevent inappropriate Tfh cell
differentiation.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice were from Taconic Farms, and Rc3h1san mice (EM:02168) were
obtained from EMMA consortia. All animals were housed in a pathogen-free
barrier facility in accordance with the Helmholtz Zentrum Mu¨nchen institu-
tional, state, and federal guidelines.
Cell Isolation, Culture, and Stimulation
Mouse embryonic fibroblasts were grown in DMEM with 10% (vol/vol) FCS,
penicillin-streptomycin (1,000 U/ml), and HEPES (10 mM), pH 7.4. CD4+
T cells were isolated from spleens and lymph nodes by using CD4 dynabeads
and detachabeads (Invitrogen) according to the manufacturer’s protocol. For
Th1 differentiation, cells were stimulated on precoated plates (goat anti-
hamster IgG; MP biochemicals) with anti-CD3 (145-2C11; 0.1–0.25 mg/ml),
anti-CD28 (37N; 1–2.5 mg/ml), anti-IL-4 (IIB11; 10 mg/ml), and recombinant
IL-12 (10 ng/ml; BD Biosciences). Anti-Ox40 (Ox86, 10 mg/ml) or isotype
antibody (rat IgG, 10 mg/ml, eBioscience) was used for NF-kB activation.
Antibodies were produced in-house unless otherwise stated. Two days after
stimulation, CD4+ T cells were cultured in the presence of recombinant hIL-2
(20 U/ml, ProleukinS, Novartis).
Virus Production and Transduction
Type 5 replication-deficient adenovirus was produced by transfection with
JetPI (Polyplus) transfectant and amplified in HEK293A cells. Cells were har-
vested and dissolved in 800 ml medium, followed by three freeze-thaw cycles.
We incubated 23 106 CD4+ CAR+ T cells with 100–300 ml virus-supernatant for
2 hr at 37C. Retrovirus production and retroviral transduction for in vitro dele-
tion and transfer is described in Supplemental Information.
Coimmunoprecipitation, Nuclear Fractionation, and Immunoblotting
For coimmunoprecipitations (coIP), mouse embryonic fibroblasts were lysed
on ice in lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.25% [vol/vol]
Nonidet-P40, 1.5 mM MgCl2, protease inhibitor mix without EDTA [Roche],
and 1 mM dithiothreitol), were shock frozen, thawed, and cleared by centrifu-
gation (10,000 g, 4C, 10 min). Anti-Rc3h1-2 (Q4-2, in-house production)
coupled to magnetic beads (Invitrogen) was incubated for 4 hr at 4C with ly-
sates. Beads were washed three times with lysis buffer and boiled in SDS
loading buffer at 95C for 5 min, and the supernatant was used for immuno-
blotting. For cytoplasmic and nuclear fractionation, cells were resuspended
in 200 ml buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 1 mM
Immunity
Roquin-1 and 2 Control Tfh Cell Differentiationdithiothreitol, protease inhibitor mix without EDTA [Roche]), incubated 15 min
on ice, and dounced 10 times. After centrifugation (10 min, 4C, 20,000 g), the
supernatant was used for immunoblotting and the pellet was washed two
times with buffer A. The nuclear and cell pellets were generally lysed for
15 min on ice in RIPA buffer (20 mM Tris-HCl, pH 7.5, 150 mMNaCl, 1% Triton
X-100, 1% sodium deoxycholate, 0.1% SDS, 5mM EDTA, 1mM dithiothreitol,
protease inhibitor mix without EDTA [Roche]). After one freeze-thaw cycle and
centrifugation immunoblotting was performed by standard protocols with
commercial antibodies (see Supplemental Information). For Roquin-1 and Ro-
quin-2 recognition we generated monoclonal antibodies (3F12) via immuniza-
tion of rats using Roquin-1 (aa 1–441) protein.
Flow Cytometry and Intracellular Staining
Single-cell suspensions of thymus and spleen were preincubated with
Fc-block (CD16/31; 2.4G2; in-house production) in staining buffer (PBS, 2%
FBS, 2 mM EDTA) for 10 min at 4C and stained with antibodies for 20 min
at 4C. All antibodies used, including those in Table S1 and Figures S3 and
S4 are described in Supplemental Information. Stainings of CXCR5, Bcl6,
Foxp3, and Roquin-1 and Roquin-2 are described in Supplemental Informa-
tion. Samples were acquired on a FACSCalibur, LSRII, or LSRFortessa (BD
Biosciences) and analyzed with FlowJo software (Tree Star).
Protein Purification
Roquin-1 (aa 1–441) was purified as described (Glasmacher et al., 2010) and
Roquin-2 (aa 1–438) was expressed from the vector pETM-11 in E. coli
Rosetta2 (DE3) and purified by affinity chromatography (HiTrap Chelating
column) and size exclusion chromatography (16/60 HiLoad Superdex 200
column). The purification buffer was 50 mM Tris-HCl pH 8.0, 300 mM NaCl,
0.01% (v/v) 1-thioglycerol.
In Vitro RNA Transcription
RNA was transcribed as described (Glasmacher et al., 2010).
Electrophoretic Mobility Shift Assay
Shift assays were performed as described (Glasmacher et al., 2010) with the
following binding buffer: 150 mM NaCl, 20 mM HEPES, pH 7.4, 1 mM
MgCl2, and 1 mM dithiothreitol, adjusted to 16% (vol/vol) glycerol.
Filter Binding Assay
On the basis of equimolar amounts of DNA oligonucleotides (Ox40 30UTR nts
999–1142 [NM_011659], Icos nts 600–700, Icos nts 700–800 [NM_012092.3]),
RNA was transcribed by using T7 RNA polymerase (Agilent Technologies) in
the presence of a-32P-UTP. After the binding reaction of 500 nM recombinant
Roquin-1 (aa 1–441) or Roquin-2 (aa 1–438) and RNA (30min at 37C in 20mM
HEPES, pH 7.4, 150 mM NaCl, 1 mM MgCl2, 1 mM dithiothreitol, and 1mg/ml
BSA), the samples were applied onto nitrocellulose filters in a dot blot device.
After five washing steps, protein-bound RNA was quantified by using a phos-
phoimager and normalized to RNA spotted onto nitrocellulose without
washing to obtain the percentage of retention. For competition experiments,
unlabeled RNA was added to the binding reaction.
Quantitative Real-Time PCR
RNA was isolated from Th1 T cell lysates with TRIzol (Life Technologies) and
reverse transcribed with the Quantitect kit (QIAGEN). Quantitative PCR assays
were run on a Light Cycler 480II device with the Light Cycler 480 SW 1.5
software. Primers and universal probes (Roche) are given in Table S2.
Statistical Analysis
Statistical analyses were performed with GraphPad Prism 5.0d and p values
were calculated by Student’s t test, one-way ANOVA, or Tukey’s multiple
comparisons test.
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